Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04436744
Brief Title: A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

First Submitted : June 16, 2020
First Submitted that Met QC Criteria : June 16, 2020
First Posted : June 18, 2020

Last Update Submitted that Met QC Criteria : January 5, 2022
Last Update Posted : January 14, 2022